Future Oncology | 2025
Real-world treatment of large B-cell lymphoma with chimeric antigen receptor T-cell therapy after loncastuximab tesirine: a plain language summary.
Hamadani M, Lucero M, DeVos JD, Chen L
PubMed
PMID: 40444351
Abstract
Related Articles
CIBMTR Study #: CS23-36